With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal. But weight loss doesn't discriminate ...

ChatGPT publisher, OpenAI, has teamed up with a longevity start-up to develop an artificial intelligence model dedicated to ...

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ...

Columbia researchers created an AI model that predicts gene activity in any human cell, advancing disease research and ...

Your body is a collection of cells carrying thousands of genetic mistakes accrued over a lifetime—many harmless, some bad and ...

Funding: Primary funding for the study was by the Burroughs Wellcome Fund Preterm Birth Initiative (1019789), the National Institutes of Health (R01AI150191, R01AI143187, F31HD106714), and the UCSF ...

Scientists at Gladstone Institutes and the regenerative medicine company SanBio have shown that a cell therapy derived from ...

Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, ...

In its latest statement, Cordlife said that the company is not able to assess the financial impact of its results for the ...